211 related articles for article (PubMed ID: 35874268)
1. Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.
Zheng Q; Lee B; Kebede MT; Ivancic VA; Kemeh MM; Brito HL; Spratt DE; Lazo ND
ACS Omega; 2022 Jul; 7(28):24757-24765. PubMed ID: 35874268
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides.
Kemeh MM; Lazo ND
ACS Chem Neurosci; 2023 Aug; 14(16):2935-2943. PubMed ID: 37498802
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme.
Zheng Q; Kebede MT; Lee B; Krasinski CA; Islam S; Wurfl LA; Kemeh MM; Ivancic VA; Jakobsche CE; Spratt DE; Lazo ND
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572974
[TBL] [Abstract][Full Text] [Related]
4. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.
González-Casimiro CM; Merino B; Casanueva-Álvarez E; Postigo-Casado T; Cámara-Torres P; Fernández-Díaz CM; Leissring MA; Cózar-Castellano I; Perdomo G
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33477364
[TBL] [Abstract][Full Text] [Related]
6. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
Leissring MA; Malito E; Hedouin S; Reinstatler L; Sahara T; Abdul-Hay SO; Choudhry S; Maharvi GM; Fauq AH; Huzarska M; May PS; Choi S; Logan TP; Turk BE; Cantley LC; Manolopoulou M; Tang WJ; Stein RL; Cuny GD; Selkoe DJ
PLoS One; 2010 May; 5(5):e10504. PubMed ID: 20498699
[TBL] [Abstract][Full Text] [Related]
7. Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme.
Maianti JP; Tan GA; Vetere A; Welsh AJ; Wagner BK; Seeliger MA; Liu DR
Nat Chem Biol; 2019 Jun; 15(6):565-574. PubMed ID: 31086331
[TBL] [Abstract][Full Text] [Related]
8. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
Saric T; Müller D; Seitz HJ; Pavelic K
Mol Cell Endocrinol; 2003 Jun; 204(1-2):11-20. PubMed ID: 12850277
[TBL] [Abstract][Full Text] [Related]
9. Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.
González-Casimiro CM; Arribas-Rodríguez E; Fiz-López A; Casas J; Gutiérrez S; Tellería P; Novoa C; Rojo-Rello S; Tamayo E; Orduña A; Dueñas C; Bernardo D; Perdomo G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232381
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
[TBL] [Abstract][Full Text] [Related]
11. Insulin-degrading enzyme is activated by the C-terminus of α-synuclein.
Sharma SK; Chorell E; Wittung-Stafshede P
Biochem Biophys Res Commun; 2015 Oct; 466(2):192-5. PubMed ID: 26343304
[TBL] [Abstract][Full Text] [Related]
12. Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner.
Sharma SK; Chorell E; Steneberg P; Vernersson-Lindahl E; Edlund H; Wittung-Stafshede P
Sci Rep; 2015 Jul; 5():12531. PubMed ID: 26228656
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
Lesire L; Leroux F; Deprez-Poulain R; Deprez B
Cells; 2022 Apr; 11(7):. PubMed ID: 35406791
[TBL] [Abstract][Full Text] [Related]
14. From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment.
Nash Y; Ganoth A; Borenstein-Auerbach N; Levy-Barazany H; Goldsmith G; Kopelevich A; Pozyuchenko K; Sakhneny L; Lazdon E; Blanga-Kanfi S; Alhadeff R; Benromano T; Landsman L; Tsfadia Y; Frenkel D
FASEB J; 2021 May; 35(5):e21374. PubMed ID: 33835493
[TBL] [Abstract][Full Text] [Related]
15. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.
McCord LA; Liang WG; Dowdell E; Kalas V; Hoey RJ; Koide A; Koide S; Tang WJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13827-32. PubMed ID: 23922390
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.
Charton J; Gauriot M; Totobenazara J; Hennuyer N; Dumont J; Bosc D; Marechal X; Elbakali J; Herledan A; Wen X; Ronco C; Gras-Masse H; Heninot A; Pottiez V; Landry V; Staels B; Liang WG; Leroux F; Tang WJ; Deprez B; Deprez-Poulain R
Eur J Med Chem; 2015 Jan; 90():547-67. PubMed ID: 25489670
[TBL] [Abstract][Full Text] [Related]
17. Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment.
Fernández-Díaz CM; Escobar-Curbelo L; López-Acosta JF; Lobatón CD; Moreno A; Sanz-Ortega J; Perdomo G; Cózar-Castellano I
Histol Histopathol; 2018 Nov; 33(11):1167-1180. PubMed ID: 29726577
[TBL] [Abstract][Full Text] [Related]
18. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
Zhang Z; Liang WG; Bailey LJ; Tan YZ; Wei H; Wang A; Farcasanu M; Woods VA; McCord LA; Lee D; Shang W; Deprez-Poulain R; Deprez B; Liu DR; Koide A; Koide S; Kossiakoff AA; Li S; Carragher B; Potter CS; Tang WJ
Elife; 2018 Mar; 7():. PubMed ID: 29596046
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.
Fernández-Díaz CM; Merino B; López-Acosta JF; Cidad P; de la Fuente MA; Lobatón CD; Moreno A; Leissring MA; Perdomo G; Cózar-Castellano I
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E805-E819. PubMed ID: 31479304
[TBL] [Abstract][Full Text] [Related]
20. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.
Kurochkin IV
FEBS Lett; 1998 May; 427(2):153-6. PubMed ID: 9607302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
